46.46.Z - Wholesale of pharmaceutical goods
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.75.Z - Wholesale of chemical products
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -2,3 | -0,7 | 71,2 |
EBITDA | -1,7 | -0,7 | 61,8 |
Short time liabilities | 0,2 | 0,7 | 306,7 |
Equity capital | 322,5 | 321,9 | -0,2 |
Operating profit (EBIT) | -1,7 | -0,7 | 61,8 |
Assets | 365,9 | 365,7 | -0 |
Net profit (loss) | -2,2 | -0,7 | 69,8 |
Cash | 0,1 | 0 | -100 |
Liabilities and provisions for liabilities | 43,3 | 43,8 | 1,2 |
Net income from sale | 0 | 0 | 0 |
Working assets | 2 | 1,8 | -7,3 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -0,7 | -0,2 | 0,5 |
Equity capital to total assets | 88,2 | 88 | -0,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 11.930421829223633 | 2.7190675735473633 | -9,2 |
Net dept to EBITDA | -18.19903564453125 | -48.60327911376953 | -30,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane